(Q37809763)

23 August 2017

title

Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation? (English)

1 reference

chronic renal insufficiency

23 August 2017

1 reference

1 reference

1

0 references

Catherine Quinlan

series ordinal

2

object named as

Catherine Quinlan

1 reference

23 August 2017

Mark Mitsnefes

3

1 reference

23 August 2017

language of work or name

1 reference

16 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

26

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

853-865

1 reference

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Cardiovascular disease in pediatric chronic dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

The vascular biology of calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Overview of the FGF23-Klotho axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Exploring the biology of vascular calcification in chronic kidney disease: what's circulating?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Latest findings in phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Serum phosphate levels and mortality risk among people with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Increased arterial stiffness in children on haemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Effects of bone and mineral metabolism on arterial elasticity in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Vascular calcification: in vitro evidence for the role of inorganic phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Calcium exposure and removal in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Arterial calcifications and bone histomorphometry in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Bone histomorphometry in children prior to commencing renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

A bimodal association of vitamin D levels and vascular disease in children on dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Vitamin D analogs for secondary hyperparathyroidism: what does the future hold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Chronic kidney disease and inflammation in pediatric patients: from bench to playground

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Malnutrition-inflammation-coronary calcification in pediatric patients receiving chronic hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Vitamin D insufficiency: implications for the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Prospective analysis of carotid arterial wall structure in pediatric renal transplants with ambulatory normotension and in treated hypertensive recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Cardiovascular effects of frequent intensive hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

The virtues of vitamin D--but how much is too much?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Phosphate binders in CKD: chalking out the differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Phosphorus binders and survival on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Home nocturnal hemodialysis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Progression of coronary calcification in pediatric chronic kidney disease stage 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

21 January 2018

Oral phosphate binders

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Emerging topics in pediatric bone and mineral disorders 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Increased arterial stiffness in young adults with end-stage renal disease since childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Multifunctional Roles for Serum Protein Fetuin-A in Inhibition of Human Vascular Smooth Muscle Cell Calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-010-1691-Y

Association of hypertriglyceridemia and insulin resistance in uremic patients undergoing CAPD.

21 January 2018

1 reference

12 December 2020

Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis

1 reference

12 December 2020

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease

1 reference

12 December 2020

Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease

1 reference

12 December 2020

Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease

1 reference

12 December 2020

Interventions for bone disease in children with chronic kidney disease

1 reference

12 December 2020

Long-term control of parathyroid hormone and calcium-phosphate metabolism after parathyroidectomy in children with chronic kidney disease

1 reference

12 December 2020

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

1 reference

12 December 2020

Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients

1 reference

12 December 2020

Mineral Metabolism and Vascular Damage in Children on Dialysis

1 reference

12 December 2020

Coronary artery calcifications in children with end-stage renal disease

1 reference

12 December 2020

Clinical epidemiology of cardiovascular disease in chronic renal disease

1 reference

12 December 2020

Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia

1 reference

12 December 2020

Monitoring cardiovascular risk factors in children on dialysis.

1 reference

12 December 2020

Cardiovascular mortality in children and young adults with end-stage kidney disease

1 reference

12 December 2020

Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

1 reference

12 December 2020

Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation

1 reference

12 December 2020

Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency

1 reference

12 December 2020

Left ventricular function and calcium phosphate plasma levels in uraemic patients

1 reference

12 December 2020

Understanding carotid artery intima-media thickness in childhood: lessons from studies in children with renal transplants

1 reference

12 December 2020

Long-Term Survival of Children with End-Stage Renal Disease

1 reference

12 December 2020

Coronary artery calcifications in children and young adults treated with renal replacement therapy

1 reference

12 December 2020

KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide

1 reference

12 December 2020

Long‐term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end‐stage renal failure patients

1 reference

12 December 2020

Vitamin D levels and early mortality among incident hemodialysis patients

1 reference

12 December 2020

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

12 December 2020

Aortic pulse wave velocity index and mortality in end-stage renal disease

1 reference

12 December 2020

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth

1 reference

12 December 2020

Vascular calcification is associated with impaired microcirculatory function in chronic haemodialysis patients

1 reference

12 December 2020

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

12 December 2020

The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis

1 reference

12 December 2020

Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study

1 reference

12 December 2020

Mortality risk among hemodialysis patients receiving different vitamin D analogs

1 reference

12 December 2020

Traditional and "new" cardiovascular risk markers and factors in pediatric dialysis patients

1 reference

12 December 2020

A new era in phosphate binder therapy: what are the options?

1 reference

12 December 2020

[Effect of oral hygiene measures on the development of pregnancy-induced periodontal changes]

1 reference

12 December 2020

10.1007/S00467-010-1691-Y

Identifiers

DOI

1 reference

23 August 2017

1 reference